Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review
Chiara Corti(University of Milan), Giuseppe Curigliano(European Institute of Oncology), Florian Scotté(University of Derby), Jean‐Marie Michot(Université Paris-Saclay), Gabriele Antonarelli(University of Milan), Fabrice André(Inserm), Jérôme Barrière(Clinique Saint Jean Languedoc), Jean‐Philippe Spano(Pitié-Salpêtrière Hospital)
Cited by 81
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
|New England Journal of Medicine|2015|1.6k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k